Literature DB >> 9405487

Divergent signaling capacities of the long and short isoforms of the leptin receptor.

C Bjørbaek1, S Uotani, B da Silva, J S Flier.   

Abstract

Leptin receptors include a long form (OBRl) with 302 cytoplasmic residues that is presumed to mediate most or all of leptins signaling, and several short forms, including one (OBRs) that has 34 cytoplasmic residues, is widely expressed, and is presumed not to signal but to mediate transport or clearance of leptin. We studied the abilities of these two receptor isoforms to mediate signaling in transfected cells. In response to leptin, OBRl, but not OBRs, underwent tyrosine phosphorylation that was enhanced by co-expression with JAK2. In cells expressing receptors and JAK2, both OBRs and OBRl mediated leptin-dependent tyrosine phosphorylation of JAK2, and this was abolished with OBRs when the Box 1 motif was mutated. In cells expressing receptors, JAK2 and IRS-1, leptin induced tyrosine phosphorylation of IRS-1 through OBRs and OBRl. In COS cells expressing hemagglutinin-ERK1 and receptors, leptin increased ERK1 kinase activity through OBRl, with the magnitude increased by co-expression of JAK1 or JAK2, and to a lesser degree through OBRs, despite greater receptor expression. In stable Chinese hamster ovary cell lines expressing OBRs or OBRl, leptin stimulated endogenous ERK2 phosphorylation. Whereas leptin stimulated tyrosine phosphorylation of hemagglutinin-STAT3 and induction of a c-fos luciferase reporter plasmid through OBRl, OBRs was without effect in these assays. In conclusion, OBRl is capable of signaling to IRS-1 and mitogen-activated protein kinase via JAK, in addition to activating STAT pathways. Although substantially weaker than OBRl, OBRs is capable of mediating signal transduction via JAK, but these activities are of as yet unknown significance for leptin biology in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405487     DOI: 10.1074/jbc.272.51.32686

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  205 in total

Review 1.  Brain effects of leptin: what intracellular mechanism?

Authors:  Kamal Rahmouni
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 4.810

Review 2.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 3.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

Review 4.  Leptin signalling pathways in hypothalamic neurons.

Authors:  Obin Kwon; Ki Woo Kim; Min-Seon Kim
Journal:  Cell Mol Life Sci       Date:  2016-01-19       Impact factor: 9.261

Review 5.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

6.  Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor.

Authors:  Zhiying Li; Giovanni Ceccarini; Michael Eisenstein; Keith Tan; Jeffrey Michael Friedman
Journal:  Mol Metab       Date:  2013-08-04       Impact factor: 7.422

7.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

8.  Buprenorphine Depresses Respiratory Variability in Obese Mice with Altered Leptin Signaling.

Authors:  Chelsea Angel; Zachary T Glovak; Wateen Alami; Sara Mihalko; Josh Price; Yandong Jiang; Helen A Baghdoyan; Ralph Lydic
Journal:  Anesthesiology       Date:  2018-05       Impact factor: 7.892

9.  Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.

Authors:  A Z Zhao; K E Bornfeldt; J A Beavo
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 10.  Impaired cardiac function in leptin-deficient mice.

Authors:  Jun Ren; Heng Ma
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.